Preventive use of gabapentin to decrease pain and systemic symptoms in patients with head and neck cancer undergoing chemoradiation.

Derek K SmithAnthony CmelakKen NiermannMichael GhiamDiane LouJill GilbertMichael K GibsonDeborah HawkinsBarbara A Murphy

Published in: Head & neck (2020)

Prophylactic use of gabapentin during chemoradiation for HNC patients resulted in a decrease in pain, neurosensory symptoms, and general systemic symptoms.

Keyphrases

neuropathic pain
chronic pain
end stage renal disease
rectal cancer
pain management
sleep quality
newly diagnosed
locally advanced
spinal cord
prognostic factors
peritoneal dialysis
drug induced